SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-138283
Filing Date
2021-04-29
Accepted
2021-04-29 07:08:00
Documents
14
Period of Report
2021-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A d839557ddef14a.htm DEF 14A 727667
2 GRAPHIC g839557dsp066a.jpg GRAPHIC 5294
3 GRAPHIC g839557dsp066b.jpg GRAPHIC 1206
4 GRAPHIC g839557dsp066c.jpg GRAPHIC 1596
5 GRAPHIC g839557dsp066d.jpg GRAPHIC 1161
6 GRAPHIC g839557dsp066f.jpg GRAPHIC 869
7 GRAPHIC g839557dsp066h.jpg GRAPHIC 864
8 GRAPHIC g839557dsp066i.jpg GRAPHIC 939
9 GRAPHIC g839557dsp066j.jpg GRAPHIC 3256
10 GRAPHIC g839557dsp066k.jpg GRAPHIC 2604
11 GRAPHIC g839557dsp067a.jpg GRAPHIC 1615
12 GRAPHIC g839557dsp067b.jpg GRAPHIC 1606
13 GRAPHIC g839557dsp067d.jpg GRAPHIC 3200
14 GRAPHIC g839557g73r69.jpg GRAPHIC 28045
  Complete submission text file 0001193125-21-138283.txt   802583
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35945 | Film No.: 21867038
SIC: 2834 Pharmaceutical Preparations